Related references
Note: Only part of the references are listed.Resolution of inflammation is altered in Alzheimer's disease
Xiuzhe Wang et al.
Alzheimers & Dementia (2015)
Resolvins attenuate inflammation and promote resolution in cigarette smoke-exposed human macrophages
Amanda Croasdell et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2015)
ω-3 Supplementation increases amyloid-β phagocytosis and resolvin D1 in patients with minor cognitive impairment
Milan Fiala et al.
FASEB JOURNAL (2015)
Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine
Aiden Haghikia et al.
IMMUNITY (2015)
Effects of n-3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: the OmegAD study
Xiuzhe Wang et al.
JOURNAL OF LIPID RESEARCH (2015)
Protection from Endotoxic Uveitis by Intravitreal Resolvin D1: Involvement of Lymphocytes, miRNAs, Ubiquitin-Proteasome, and M1/M2 Macrophages
S. Rossi et al.
MEDIATORS OF INFLAMMATION (2015)
The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution
Charles N. Serhan et al.
SEMINARS IN IMMUNOLOGY (2015)
Pivotal role of choline metabolites in remyelination
Thomas Skripuletz et al.
BRAIN (2015)
Resolvins, Specialized Proresolving Lipid Mediators, and Their Potential Roles in Metabolic Diseases
Matthew Spite et al.
CELL METABOLISM (2014)
Disease-modifying therapy in multiple sclerosis and chronic inflammatory demyelinating polyradiculoneuropathy: common and divergent current and future strategies
N. Melzer et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Resolvin D1 improves survival in experimental sepsis through reducing bacterial load and preventing excessive activation of inflammatory response
F. Chen et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2014)
Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages
Antonio Recchiuti et al.
FASEB JOURNAL (2014)
Resolvin D1 primes the resolution process initiated by calorie restriction in obesity-induced steatohepatitis
Bibiana Rius et al.
FASEB JOURNAL (2014)
Proresolving Lipid Mediators and Mechanisms in the Resolution of Acute Inflammation
Christopher D. Buckley et al.
IMMUNITY (2014)
Protective Actions of Aspirin-Triggered (17R) Resolvin D1 and Its Analogue, 17R-Hydroxy-19-Para-Fluorophenoxy-Resolvin D1 Methyl Ester, in C5a-Dependent IgG Immune Complex-Induced Inflammation and Lung Injury
Huifang Tang et al.
JOURNAL OF IMMUNOLOGY (2014)
Resolvin D1 promotes the interleukin-4-induced alternative activation in BV-2 microglial cells
Longyan Li et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Special lipid-based diets alleviate cognitive deficits in the APPswe/PS1dE9 transgenic mouse model of Alzheimer's disease independent of brain amyloid deposition
Hennariikka Koivisto et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2014)
Pro-resolving lipid mediators are leads for resolution physiology
Charles N. Serhan
NATURE (2014)
Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation
Lior Mayo et al.
NATURE MEDICINE (2014)
n-3 PUFA supplementation benefits microglial responses to myelin pathology
Songela Chen et al.
SCIENTIFIC REPORTS (2014)
Kynurenines in CNS disease: regulation by inflammatory cytokines
Brian M. Campbell et al.
FRONTIERS IN NEUROSCIENCE (2014)
Potential of Urinary Metabolites for Diagnosing Multiple Sclerosis
Teklab Gebregiworgis et al.
ACS CHEMICAL BIOLOGY (2013)
Recent advances in metabolomics in neurological disease, and future perspectives
Ai-hua Zhang et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2013)
The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders
Trevor W. Stone et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Association of fish consumption and omega 3 supplementation with quality of life, disability and disease activity in an international cohort of people with multiple sclerosis
George A. Jelinek et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2013)
Cerebral Biochemical Pathways in Experimental Autoimmune Encephalomyelitis and Adjuvant Arthritis: A Comparative Metabolomic Study
Norbert W. Lutz et al.
PLOS ONE (2013)
A Novel Anti-Inflammatory and Pro-Resolving Role for Resolvin D1 in Acute Cigarette Smoke-Induced Lung Inflammation
Hsi-Min Hsiao et al.
PLOS ONE (2013)
Novel n-3 Immunoresolvents: Structures and Actions
Jesmond Dalli et al.
SCIENTIFIC REPORTS (2013)
ω-3 Fatty Acid Treatment in Multiple Sclerosis (OFAMS Study) A Randomized, Double-Blind, Placebo-Controlled Trial
Oivind Torkildsen et al.
ARCHIVES OF NEUROLOGY (2012)
Adoptive Transfer of Immunomodulatory M2 Macrophages Prevents Type 1 Diabetes in NOD Mice
Roham Parsa et al.
DIABETES (2012)
First-Line Disease-Modifying Therapies in Paediatric Multiple Sclerosis
Jessica Johnston et al.
DRUGS (2012)
Myeloid-derived suppressor cells in transplantation and cancer
Jordi C. Ochando et al.
IMMUNOLOGIC RESEARCH (2012)
Challenges and opportunities of metabolomics
Caroline H. Johnson et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Resolvin D1 and Aspirin-Triggered Resolvin D1 Promote Resolution of Allergic Airways Responses
Alexandre P. Rogerio et al.
JOURNAL OF IMMUNOLOGY (2012)
Identification of a new plasma biomarker of Alzheimer's disease using metabolomics technology
Yoshiaki Sato et al.
JOURNAL OF LIPID RESEARCH (2012)
Infection regulates pro-resolving mediators that lower antibiotic requirements
Nan Chiang et al.
NATURE (2012)
Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosis
Marek J. Noga et al.
METABOLOMICS (2012)
MetaboAnalyst 2.0-a comprehensive server for metabolomic data analysis
Jianguo Xia et al.
NUCLEIC ACIDS RESEARCH (2012)
Laquinimod, a Quinoline-3-Carboxamide, Induces Type II Myeloid Cells That Modulate Central Nervous System Autoimmunity
Ulf Schulze-Topphoff et al.
PLOS ONE (2012)
Defects in Mitochondrial Dynamics and Metabolomic Signatures of Evolving Energetic Stress in Mouse Models of Familial Alzheimer's Disease
Eugenia Trushina et al.
PLOS ONE (2012)
Identification of Naturally Occurring Fatty Acids of the Myelin Sheath That Resolve Neuroinflammation
Peggy P. Ho et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
The role of metabolites and metabolomics in clinically applicable biomarkers of disease
Mamas Mamas et al.
ARCHIVES OF TOXICOLOGY (2011)
Docosahexaenoic acid prevents dendritic cell maturation, inhibits antigen-specific Th1/Th17 differentiation and suppresses experimental autoimmune encephalomyelitis
Weimin Kong et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats
J. F. Lima-Garcia et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Proteomics-Based Technologies in the Discovery of Biomarkers for Multiple Sclerosis in the Cerebrospinal Fluid
A. S.T. Lourenco et al.
CURRENT MOLECULAR MEDICINE (2011)
Resolvin D1 and Its Precursor Docosahexaenoic Acid Promote Resolution of Adipose Tissue Inflammation by Eliciting Macrophage Polarization toward an M2-Like Phenotype
Esther Titos et al.
JOURNAL OF IMMUNOLOGY (2011)
Omega-3 Fatty Acid-Derived Mediators 17(R)-Hydroxy Docosahexaenoic Acid, Aspirin-Triggered Resolvin D1 and Resolvin D2 Prevent Experimental Colitis in Mice
Allisson Freire Bento et al.
JOURNAL OF IMMUNOLOGY (2011)
LC-MS based serum metabonomic analysis for renal cell carcinoma diagnosis, staging, and biomarker discovery
Lin Lin et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Repertoire of microglial and macrophage responses after spinal cord injury
Samuel David et al.
NATURE REVIEWS NEUROSCIENCE (2011)
DRUG THERAPY n-3 Fatty Acids in Cardiovascular Disease
Raffaele De Caterina
NEW ENGLAND JOURNAL OF MEDICINE (2011)
FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation
Ji Woong Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Protective and pathogenic functions of macrophage subsets
Peter J. Murray et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Resolvins as Regulators of the Immune System
Hiroyuki Seki et al.
THESCIENTIFICWORLDJOURNAL (2010)
Organization of GC/MS and LC/MS metabolomics data into chemical libraries
Corey D DeHaven et al.
Journal of Cheminformatics (2010)
Integrated, Nontargeted Ultrahigh Performance Liquid Chromatography/Electrospray Ionization Tandem Mass Spectrometry Platform for the Identification and Relative Quantification of the Small-Molecule Complement of Biological Systems
Anne M. Evans et al.
ANALYTICAL CHEMISTRY (2009)
Loss of AMPK exacerbates experimental autoimmune encephalomyelitis disease severity
Narender Nath et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Resolvin D1 controls inflammation initiated by glutathione-lipid conjugates formed during oxidative stress
M. Spite et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Metformin Attenuated the Autoimmune Disease of the Central Nervous System in Animal Models of Multiple Sclerosis
Narender Nath et al.
JOURNAL OF IMMUNOLOGY (2009)
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Arun Sreekumar et al.
NATURE (2009)
MetaboAnalyst: a web server for metabolomic data analysis and interpretation
Jianguo Xia et al.
NUCLEIC ACIDS RESEARCH (2009)
Metabolomic Profiling in LRRK2-Related Parkinson's Disease
Krisztina K. Johansen et al.
PLOS ONE (2009)
Discovery of Metabolomics Biomarkers for Early Detection of Nephrotoxicity
Kurt J. Boudonck et al.
TOXICOLOGIC PATHOLOGY (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics
Naoki Umemura et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Systems biology - Metabonomics
Jeremy K. Nicholson et al.
NATURE (2008)
Analysis of the adult human plasma metabolome
Kay A. Lawton et al.
PHARMACOGENOMICS (2008)
Omega-3 fatty acids and multiple sclerosis: relationship to depression
Robin L. Aupperle et al.
JOURNAL OF BEHAVIORAL MEDICINE (2008)
CD11b+Ly-6Chi suppressive monocytes in experimental autoimmune encephalomyelitis
Bing Zhu et al.
JOURNAL OF IMMUNOLOGY (2007)
Type II monocytes modulate T cell-mediated central nervous system autoimmune disease
Martin S. Weber et al.
NATURE MEDICINE (2007)
Analyzing gene expression data in terms of gene sets:: methodological issues
Jelle J. Goeman et al.
BIOINFORMATICS (2007)
Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration
S. Schilling et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-γ- and CD40L-mediated costimulation
Frank A. W. Verreck et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Graph-based methods for analysing networks in cell biology
Tero Aittokallio et al.
BRIEFINGS IN BIOINFORMATICS (2006)
Low fat dietary intervention with ω-3 fatty acid supplementation in multiple sclerosis patients
B Weinstock-Guttman et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2005)
A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease
WJ Lukiw et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide
A Jahng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Resolvins: A family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals
CN Serhan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients
I Nordvik et al.
ACTA NEUROLOGICA SCANDINAVICA (2000)
Share Paper
